Tasks required to nurture domestic pharmaceutical firms' competitiveness

In light of the increasingly competitive pharmaceutical environment in the global market, domestic drug makers should retain better profitability in a bide to ensure substantial R&D spending, strengthened export drive and streamlined R&D activities to expand Korea's infrastructure for the development of global new drugs, Dr. Lee Chong-wook of Yuhan Corporation, said in a recent seminar.

Spe...